In an effort to better understand the access challenges across the US, Hims & Hers introduced the GLP-1 Supply Tracker to help more individuals share their experiences and use their voice to ensure the FDA has the information it needs to better support accessible care
Call your healthcare provider without delay if you experience persistent vomiting, severe diarrhea, severe abdominal pain, inability to pass gas or have bowel movements, dehydration, or jaundice (yellow discoloration of the skin and/or eyes)
Information on GLP-1 Users In a recent Numerator survey with over 100,000 respondents in the U.S., 11.8% indicated they had at least one GLP-1 user in their household
Clinical studies We split this section between studies of GLP-1RAs in people with mood disorders and studies of mood symptoms in patients with other medical conditions taking GLP-1RAs (Tables 4 and 5, and Extended Data Tables 5 and 6)
Optimal metabolic function requires both sufficient hormone production and robust receptor-mediated signaling
Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation